Morphological changes in the rat neostriatum after unilateral 6-hydroxydopamine injections into the nigrostriatal pathway. 1993

C A Ingham, and S H Hood, and B van Maldegem, and A Weenink, and G W Arbuthnott
Department of Preclinical Veterinary Sciences, University of Edinburgh, Summerhall, UK.

Destruction of the dopamine-containing neurons in the rat substantia nigra results in morphological changes in the striatum which have been characterized at both the light and electron microscopic levels. After a unilateral 6-hydroxydopamine injection into the medial forebrain bundle, Golgi-impregnated medium-sized spiny neurons in the neostriatum ipsilateral to the injection had a lower density of spines on their dendrites than those on the contralateral side. A similar decrease in spine density was apparent from 12 days until at least 13.5 months after the lesion. A bilateral loss of spines occurred with increasing age regardless of the presence or absence of the nigrostriatal dopaminergic pathway. At the ultrastructural level, the general pattern of synaptic input to the Golgi-impregnated medium-sized spiny neurons was similar on both sides of the brain. The most obvious class of afferent boutons contacting these spiny neurons formed prominent asymmetrical synaptic specializations with the heads of the spines. The numbers of asymmetric synaptic profiles counted in random electron micrographs from the striata ipsilateral and contralateral to the lesion were not significantly different from each other. A small but significant increase in the length of asymmetric synaptic specialization profiles was, however, detected in the striata lacking a dopamine input.

UI MeSH Term Description Entries
D007267 Injections Introduction of substances into the body using a needle and syringe. Injectables,Injectable,Injection
D008297 Male Males
D009434 Neural Pathways Neural tracts connecting one part of the nervous system with another. Neural Interconnections,Interconnection, Neural,Interconnections, Neural,Neural Interconnection,Neural Pathway,Pathway, Neural,Pathways, Neural
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D003712 Dendrites Extensions of the nerve cell body. They are short and branched and receive stimuli from other NEURONS. Dendrite
D006651 Histocytochemistry Study of intracellular distribution of chemicals, reaction sites, enzymes, etc., by means of staining reactions, radioactive isotope uptake, selective metal distribution in electron microscopy, or other methods. Cytochemistry
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013194 Staining and Labeling The marking of biological material with a dye or other reagent for the purpose of identifying and quantitating components of tissues, cells or their extracts. Histological Labeling,Staining,Histological Labelings,Labeling and Staining,Labeling, Histological,Labelings, Histological,Stainings

Related Publications

C A Ingham, and S H Hood, and B van Maldegem, and A Weenink, and G W Arbuthnott
December 1998, Experimental neurology,
C A Ingham, and S H Hood, and B van Maldegem, and A Weenink, and G W Arbuthnott
January 1990, Neuroscience,
C A Ingham, and S H Hood, and B van Maldegem, and A Weenink, and G W Arbuthnott
May 1978, Life sciences,
C A Ingham, and S H Hood, and B van Maldegem, and A Weenink, and G W Arbuthnott
August 1973, Experimental neurology,
C A Ingham, and S H Hood, and B van Maldegem, and A Weenink, and G W Arbuthnott
April 1994, Biulleten' eksperimental'noi biologii i meditsiny,
C A Ingham, and S H Hood, and B van Maldegem, and A Weenink, and G W Arbuthnott
August 2003, British journal of pharmacology,
C A Ingham, and S H Hood, and B van Maldegem, and A Weenink, and G W Arbuthnott
March 1979, Experimental neurology,
C A Ingham, and S H Hood, and B van Maldegem, and A Weenink, and G W Arbuthnott
January 1980, Comptes rendus des seances de la Societe de biologie et de ses filiales,
C A Ingham, and S H Hood, and B van Maldegem, and A Weenink, and G W Arbuthnott
August 1972, European journal of pharmacology,
C A Ingham, and S H Hood, and B van Maldegem, and A Weenink, and G W Arbuthnott
August 1978, Brain research,
Copied contents to your clipboard!